Oxidative stress and Parkinson’s disease

Home visits: a strategy to improve newborn survival - Authors' reply

(2008) · Americanae (AECID Library) · doi:10.1016/s0140 · Cited by 22,524 · see citing works

Microglia-mediated neurotoxicity: uncovering the molecular mechanisms

Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · see citing works

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

Betarbet, R., Sherer, T., Mackenzie, G., Garcia-Osuna, M., Panov, A., & Greenamyre, J. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,797 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease

Pickrell, A. M., & Youle, R. J. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.007 · Cited by 2,310 · see citing works

Mitochondrial Complex I Deficiency in Parkinson's Disease

Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · see citing works

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · see citing works

Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin

Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · see citing works

MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE

Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757 · see citing works

100 years of Lewy pathology

Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190 · see citing works

Reactive oxygen species: from health to disease

Brieger, K., Schiavone, S., Miller Jr., F. J., & Krause, K.-H. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13659 · Cited by 1,133 · see citing works

The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization

Canet-Aviles, R., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,115 · see citing works

Mitochondrial Dysfunction and Oxidative Damage in parkin-deficient Mice

Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., Klose, J., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401135200 · Cited by 995 · see citing works

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883 · see citing works

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

Rodríguez‐Oroz, M., Jahanshahi, M., Krack, P., Litvan, I., Macías, R. J., Bézard, E., & Obeso, J. A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70293-5 · Cited by 866 · see citing works

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856 · see citing works

Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of <i>Drosophila</i> Pink1 is rescued by Parkin

Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.-W., Yang, L., Beal, M. F., Vogel, H., & Lu, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602493103 · Cited by 798 · see citing works

Missing pieces in the Parkinson's disease puzzle

Obeso, J. A., Rodríguez‐Oroz, M., Goetz, C. G., Marin, C. A., Kordower, J. H., Rodrı́guez, M., Hirsch, É. C., Farrer, M. J., Schapira, A. H. V., & Halliday, G. M. (2010) · Nature Medicine · doi:10.1038/nm.2165 · Cited by 737 · see citing works

Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease

Mizuno, Y., Ohta, S., Tanaka, M., Takamiya, S., Suzuki, K., SATO, T. A., Oya, H., Ozawa, T., & Kagawa, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91141-8 · Cited by 735 · see citing works

Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation

Sherer, T., Kim, J.-H., Betarbet, R. S., & Greenamyre, J. T. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8072 · Cited by 707 · see citing works

Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress

Gautier, C. A., Kitada, T., & Shen, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802076105 · Cited by 698 · see citing works

Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death

Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684 · see citing works

Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria

Berman, S. B., & Hastings, T. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731127.x · Cited by 664 · see citing works

Etiology and pathogenesis of Parkinson's disease

Schapira, A. H. V., & Jenner, P. G. (2011) · Movement Disorders · doi:10.1002/mds.23732 · Cited by 659 · see citing works

Impaired dopamine release and synaptic plasticity in the striatum of PINK1 -deficient mice

Kitada, T., Pisani, A., Porter, D. R., Yamaguchi, H., Tscherter, A., Martella, G., Bonsi, P., Zhang, C., Pothos, E. N., & Shen, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702717104 · Cited by 541 · see citing works

Nigrostriatal Dopaminergic Deficits and Hypokinesia Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1

Goldberg, M. S., Pisani, A., Haburčák, M., Vortherms, T. A., Kitada, T., Costa, C., Tong, Y., Martella, G., Tscherter, A., Martins, A., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.041 · Cited by 532 · see citing works

Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease

Ryan, B. J., Hoek, S., Fon, E. A., & Wade-Martins, R. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.02.003 · Cited by 524 · see citing works

Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson’s disease

Asanuma, M., Miyazaki, I., & Ogawa, N. (2003) · Neurotoxicity Research · doi:10.1007/bf03033137 · Cited by 518 · see citing works

Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin

Exner, N., Treske, B., Paquet, D., Holmström, K. M., Schiesling, C., Gispert, S., Carballo‐Carbajal, I., Berg, D., Hoepken, H.-H., Gasser, T., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0719-07.2007 · Cited by 511 · see citing works

Protective and toxic roles of dopamine in Parkinson's disease

Segura‐Aguilar, J., Paris, I. B., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12686 · Cited by 499 · see citing works

Parkinson’s disease: animal models and dopaminergic cell vulnerability

Blesa, J., & Przedborski, S. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00155 · Cited by 483 · see citing works

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease

Bandopadhyay, R. (2004) · Brain · doi:10.1093/brain/awh054 · Cited by 466 · see citing works

Advances in the genetics of Parkinson disease

Trinh, J., & Farrer, M. J. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.132 · Cited by 465 · see citing works

LRRK2 Inhibition Attenuates Microglial Inflammatory Responses

Moehle, M. S., Webber, P. J., Tse, T., Sukar, N., Standaert, D. G., DeSilva, T. M., Cowell, R. M., & West, A. B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5601-11.2012 · Cited by 463 · see citing works

Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles

Sulzer, D. L., Bogulavsky, J. J., Larsen, K. E., Behr, G. G., Karatekin, E., Kleinman, M. H., Turro, N. J., Krantz, D. E., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 460 · see citing works

Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing

Hall, C. N., Klein-Flugge, M. C., Howarth, C., & Attwell, D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0026-12.2012 · Cited by 451 · see citing works

Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease

Haas, R. H., Nasirian, F., Nakano, K., Ward, D., Pay, M., Hill, R., & Shults, C. W. (1995) · Annals of Neurology · doi:10.1002/ana.410370604 · Cited by 435 · see citing works

Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis

Zhang, L., Shimoji, M., Thomas, B., Moore, D. J., Yu, S.-W., Marupudi, N. I., Torp, R., Torgner, I. A., Ottersen, O. P., Dawson, T. M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi211 · Cited by 418 · see citing works

Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives

Schapira, A. H. V., Olanow, C. W., Greenamyre, J. T., & Bézard, E. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61010-2 · Cited by 392 · see citing works

Parkin and PINK1: much more than mitophagy

Scarffe, L. A., Stevens, D. A., Dawson, V. L., & Dawson, T. M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.03.004 · Cited by 392 · see citing works

Reduced Vesicular Storage of Dopamine Causes Progressive Nigrostriatal Neurodegeneration

Caudle, W. M., Richardson, J. R., Wang, M. Z., Taylor, T. N., Guillot, T. S., McCormack, A. L., Colebrooke, R. E., Monte, D. A. D., Emson, P. C., & Miller, G. W. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0319-07.2007 · Cited by 389 · see citing works

Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics

Irrcher, I., Aleyasin, H., Seifert, E. L., Hewitt, S. J., Chhabra, S., Phillips, M., Lutz, A. K., Rousseaux, M. W. C., Bevilacqua, L., Jahani‐Asl, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq288 · Cited by 386 · see citing works

Complex I deficiency in Parkinson's disease frontal cortex

Parker, W. D., Parks, J. K., & Swerdlow, R. H. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.061 · Cited by 383 · see citing works

Conjugates of Catecholamines with Cysteine and GSH in Parkinson's Disease: Possible Mechanisms of Formation Involving Reactive Oxygen Species

Spencer, J. P. E., Jenner, P., Daniel, S. E., Lees, A. J., Marsden, D. C., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052112.x · Cited by 373 · see citing works

Reduced Basal Autophagy and Impaired Mitochondrial Dynamics Due to Loss of Parkinson's Disease-Associated Protein DJ-1

Krebiehl, G., Ruckerbauer, S., Burbulla, L. F., Kieper, N., Maurer, B., Waak, J., Wolburg, H., Gizatullina, Z. Z., Gellerich, F. N., Woitalla, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009367 · Cited by 370 · see citing works

HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration

Gao, H.-M., Zhou, H., Zhang, F., Wilson, B. C., Kam, W., & Hong, J.-S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3732-10.2011 · Cited by 369 · see citing works

Platelet mitochondria function in Parkinson's disease

Krige, D., Carroll, M. T., Cooper, J. A. D., MARSDEN, C. D., & Schapira, A. H. V. (1992) · Annals of Neurology · doi:10.1002/ana.410320612 · Cited by 358 · see citing works

Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons

Gao, H., Liu, B., & Hong, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06181.2003 · Cited by 338 · see citing works

Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice

Sacino, A. N., Brooks, M., Thomas, M. A., McKinney, A. B., Lee, S., Regenhardt, R. W., McGarvey, N. H., Ayers, J. I., Notterpek, L. M., Borchelt, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321785111 · Cited by 328 · see citing works

Mitochondrial localization of DJ‐1 leads to enhanced neuroprotection

Junn, E., Jang, W. H., Zhao, X., Jeong, B. S., & Mouradian, M. M. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21831 · Cited by 320 · see citing works

Selective microglial activation in the rat rotenone model of Parkinson's disease

Sherer, T., Betarbet, R. S., Kim, J.-H., & Greenamyre, J. T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00172-1 · Cited by 317 · see citing works

PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons

Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. S. Y., Miljan, E. A., Keen, G., Stanyer, L., Hargreaves, I., Klupsch, K., Deas, E., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002455 · Cited by 316 · see citing works

Intraneuronal dopamine-quinone synthesis: a review

Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284 · see citing works

Microglial Reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) Induced Parkinson's Disease Mice Model

Członkowska, A., Kohutnicka, M., Kurkowska‐Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279 · see citing works

Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in parkinson's disease

Hattori, N., Tanaka, M., Ozawa, T., & Mizuno, Y. (1991) · Annals of Neurology · doi:10.1002/ana.410300409 · Cited by 275 · see citing works

Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease

Pisanu, A., Lecca, D., Mulas, G., Wardas, J., Simbula, G., Spiga, S., & Carta, A. R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.011 · Cited by 268 · see citing works

Parkin Deficiency Increases Vulnerability to Inflammation-Related Nigral Degeneration

Frank-Cannon, T. C., Tran, T. A. T., Ruhn, K. A., Martinez, T. N., Hong, J. J., Marvin, M. A., Hartley, M., Treviño, I., O’Brien, D. E., Casey, B. H., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.3001-08.2008 · Cited by 262 · see citing works

Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease

Zhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257 · see citing works

Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson’s disease patients

Doorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D., Lucassen, P. J., & van Dam, A.-M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0090-1 · Cited by 254 · see citing works

Neuromelanin of the Human Substantia Nigra: An Update

Zucca, F. A., Basso, E., Cupaioli, F. A., Ferrari, E., Sulzer, D., Casella, L., & Zecca, L. (2014) · Neurotoxicity Research · doi:10.1007/s12640-013-9435-y · Cited by 243 · see citing works

Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein

Watson, M. B., Richter, F., Lee, S., Gabby, L. C., Wu, J. E., Masliah, E., Effros, R. B., & Chesselet, M. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.025 · Cited by 241 · see citing works

Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations

Puschmann, A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.01.020 · Cited by 238 · see citing works

Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations

Müftüoğlu, M., Elibol, B., Dalmızrak, Ö., Ercan, A., Kulaksiz-Erkmen, G., Öğüş, İ. H., Dalkara, T., & Özer, N. (2003) · Movement Disorders · doi:10.1002/mds.10695 · Cited by 237 · see citing works

Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease

Hattingen, E., Magerkurth, J., Pilatus, U., Mozer, A., Seifried, C., Steinmetz, H., Zanella, F. E., & Hilker, R. (2009) · Brain · doi:10.1093/brain/awp293 · Cited by 224 · see citing works

Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats

Daher, J. P. L., Volpicelli-Daley, L. A., Blackburn, J. P., Moehle, M. S., & West, A. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403215111 · Cited by 223 · see citing works

Effects of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine and 1‐Methyl‐4‐Phenylpyridinium Ion on Activities of the Enzymes in the Electron Transport System in Mouse Brain

Mizuno, Y., Sone, N., & Saitoh, T. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb05737.x · Cited by 222 · see citing works

Parkinson's disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity

Gillardon, F., Schmid, R. A., & Draheim, H. J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.001 · Cited by 219 · see citing works

α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease

Halliday, G. M., Ophof, A., Broe, M., Jensen, P. H., Kettle, E., Fedorow, H., Cartwright, M., Carew‐Jones, F., Shepherd, C. E., & Double, K. L. (2005) · Brain · doi:10.1093/brain/awh584 · Cited by 219 · see citing works

Calcium Entry and -Synuclein Inclusions Elevate Dendritic Mitochondrial Oxidant Stress in Dopaminergic Neurons

Dryanovski, D. I., Guzmán, J. N., Xie, Z., Galteri, D. J., Volpicelli‐Daley, L. A., Lee, V. M. Y., Miller, R. J., Schumacker, P. T., & Surmeier, D. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5311-12.2013 · Cited by 213 · see citing works

Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure

Barcia, C., Sánchez-Bahíllo, A., Fernández‐Villalba, E., Bautista‐Hernández, V., Poza, M., Fernández-Barreiro, A., Hirsch, É. C., & Herrero, M. T. (2004) · Glia · doi:10.1002/glia.20015 · Cited by 206 · see citing works

Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6

Hoepken, H.-H., Gispert, S., Morales, B., Wingerter, O., Turco, D. D., Mülsch, A., Nussbaum, R. L., Müller, K., Dröse, S., Brandt, U., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.007 · Cited by 202 · see citing works

Parkinson's disease: Evidence for environmental risk factors

Kieburtz, K. D., & Wunderle, K. B. (2012) · Movement Disorders · doi:10.1002/mds.25150 · Cited by 199 · see citing works

DJ-1 binds to mitochondrial complex I and maintains its activity

Hayashi, T., Ishimori, C., Takahashi-Niki, K., Taira, T., Kim, Y.-C., Maita, H., Maita, C., Ariga, H., & Iguchi‐Ariga, S. M. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.025 · Cited by 199 · see citing works

Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease

Yoshino, H., Nakagawa-Hattori, Y., Kondo, T., & Mizuno, Y. (1992) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257619 · Cited by 195 · see citing works

Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter

Whitehead, R. E., Ferrer, J. V., Javitch, J. A., & Justice, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00125.x · Cited by 194 · see citing works

The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease

Zuo, L., & Motherwell, M. S. (2013) · Gene · doi:10.1016/j.gene.2013.07.085 · Cited by 194 · see citing works

The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease

Joglar, B., Rodríguez‐Pallares, J., Rodriguez-Perez, A. I., Rey, P., Guerra, M. J., & Labandeira-García, J. L. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05999.x · Cited by 190 · see citing works

Regulation of astrocyte inflammatory responses by the Parkinson's disease‐associated gene DJ–1

Waak, J., Weber, S. S., Waldenmaier, A., Görner, K., Alunni‐Fabbroni, M., Schell, H., Weisenhorn, D. M. V., Pham, T., Reumers, V., Baekelandt, V., et al. (2009) · The FASEB Journal · doi:10.1096/fj.08-125153 · Cited by 186 · see citing works

Tyrosine Hydroxylase Is Inactivated by Catechol‐Quinones and Converted to a Redox‐Cycling Quinoprotein

Kuhn, D. M., Arthur, R. E., Thomas, D. M., & Elferink, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731309.x · Cited by 183 · see citing works

Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy

Blin, O. J., Desnuelle, C., Rascol, O., Borg, M., Paul, H. P. S., Azulay, J., Billé, F., Figarella-Branger, D. F., Coulom, F., Pellissier, J., et al. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90248-8 · Cited by 182 · see citing works

Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using Neuromelanin-sensitive MR imaging

Ohtsuka, C., Sasaki, M., Konno, K., Koide, M., Kato, K., Takahashi, J., Takahashi, S., Kudo, K., Yamashita, F., & Terayama, Y. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.012 · Cited by 171 · see citing works

Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits

Masoud, S. T., Vecchio, L. M., Bergeron, Y., Hossain, M. M., Nguyen, L., Bermejo, M. K., Kile, B. M., Sotnikova, T. D., Siesser, W. B., Gainetdinov, R. R., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.016 · Cited by 158 · see citing works

Lessons from the rotenone model of Parkinson’s disease

Greenamyre, J., Cannon, J. R., Drolet, R., & Mastroberardino, P. (2010) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.12.006 · Cited by 154 · see citing works

Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging

Ohtsuka, C., Sasaki, M., Konno, K., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.04.005 · Cited by 154 · see citing works

Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity

Xiang, W., Schlachetzki, J. C. M., Helling, S., Bussmann, J., Berlinghof, M., Schäffer, T. E., Marcus, K., Winkler, J., Klucken, J., & Becker, C. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.01.004 · Cited by 152 · see citing works

Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells

Laar, V. S. V., Mishizen-Eberz, A. J., Cascio, M., & Hastings, T. G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.004 · Cited by 151 · see citing works

Methamphetamine Causes Degeneration of Dopamine Cell Bodies and Terminals of the Nigrostriatal Pathway Evidenced by Silver Staining

Ares‐Santos, S., Granado, N., Espadas, I., Martínez‐Murillo, R., & Moratalla, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.307 · Cited by 151 · see citing works

Disruption of Protein Quality Control in Parkinson's DiseasePreprint

Cook, C. N., Stetler, C. T., & Petrucelli, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009423 · Cited by 145 · see citing works

Time course of dopamine neuron loss and glial response in the 6‐ OHDA striatal mouse model of P arkinson's disease

Stott, S., & Barker, R. A. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12459 · Cited by 143 · see citing works

α-Synuclein Expression Modulates Microglial Activation Phenotype

Austin, S. A., Floden, A. M., Murphy, E. J., & Combs, C. K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-06.2006 · Cited by 142 · see citing works

Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors

Surace, M. J., & Block, M. L. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1015-4 · Cited by 131 · see citing works

The Parkinson’s-associated protein DJ-1 regulates the 20S proteasome

Moscovitz, O., Ben‐Nissan, G., Fainer, I., Pollack, D., Mizrachi, L., & Sharon, M. (2015) · Nature Communications · doi:10.1038/ncomms7609 · Cited by 126 · see citing works

Complex I: Inhibitors, inhibition and neurodegeneration

Schapira, A. H. V. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.028 · Cited by 125 · see citing works

PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons

Wang, H., Chou, A.-H., Wu, A.-S., Chen, S.-Y., Weng, Y.-H., Kao, Y.-C., Yeh, T., Chu, P., & Lu, C.-S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.03.007 · Cited by 121 · see citing works

Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein

Subramaniam, S., Vergnes, L., Franich, N. R., Reue, K., & Chesselet, M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.017 · Cited by 119 · see citing works

Glial Dysfunction in Parkin Null Mice: Effects of Aging

Solano, R. M., Casarejos, M. J., Menéndez-Cuervo, J., Rodríguez‐Navarro, J. A., de Yébenes, J. G., & Mena, M. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4609-07.2008 · Cited by 119 · see citing works

Role of oxidative changes in the degeneration of dopamine terminals after injection of neurotoxic levels of dopamine

Rabinovic, A. D., Lewis, D. A., & Hastings, T. G. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00293-1 · Cited by 117 · see citing works

Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease

Jana, S., Sinha, M. S., Chanda, D., Roy, T., Banerjee, K., Munshi, S., Patro, B. S., & Chakrabarti, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.02.013 · Cited by 115 · see citing works

Innate Inflammation in Parkinson's DiseasePreprint

Perry, V. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009373 · Cited by 113 · see citing works

Lipopolysaccharide and Tumor Necrosis Factor Regulate Parkin Expression via Nuclear Factor-Kappa B

Tran, T. A. T., Nguyen, A. D., Chang, J., Goldberg, M. S., Lee, J., & Tansey, M. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023660 · Cited by 112 · see citing works

Methamphetamine‐induced dopaminergic neurotoxicity is regulated by quinone formation‐related molecules

Miyazaki, I., Asanuma, M., Diaz-Corrales, F. J. J., Fukuda, M., Kitaichi, K., Miyoshi, K., & Ogawa, N. (2006) · The FASEB Journal · doi:10.1096/fj.05-4996fje · Cited by 111 · see citing works

Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?

Herrero, M. T., Hirsch, É. C., Kästner, A., et al. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90349-k · Cited by 109 · see citing works

Evidence for a common biological pathway linking three Parkinson's disease‐causing genes: parkin, PINK1 and DJ‐1

van der Merwe, C., Dashti, Z. J. S., Christoffels, A. G., Loos, B., & Bardien, S. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.12872 · Cited by 106 · see citing works

Mitochondrial Respiratory Dysfunction in Familiar Parkinsonism Associated with PINK1 Mutation

Piccoli, C., Sardanelli, A. M., Scrima, R., Ripoli, M. C., Quarato, G., D’Aprile, A., Bellomo, F., Scacco, S., Michele, G. D., Filla, A., et al. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9729-2 · Cited by 105 · see citing works

Increased Amoeboid Microglial Density in the Olfactory Bulb of Parkinson's and Alzheimer's Patients

Doorn, K. J., Goudriaan, A., Blits-Huizinga, C., Bol, J., Rozemuller, A., Hoogland, P., Lucassen, P., Drukarch, B., van de Berg, W. V. D., & van Dam, A.-M. W. (2014) · Brain Pathology · doi:10.1111/bpa.12088 · Cited by 104 · see citing works

DJ-1 facilitates the interaction between STAT1 and its phosphatase, SHP-1, in brain microglia and astrocytes: A novel anti-inflammatory function of DJ-1

Kim, J.-H., Choi, D.-J., Jeong, H.-K., Kim, J., Kim, D. W., Choi, S. Y., Park, S.-M., Suh, Y. H., Jou, I., & Joe, E.-H. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.007 · Cited by 102 · see citing works

Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells

Perfeito, R., Lázaro, D. F., Outeiro, T. F., & Rego, A. C. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.08.002 · Cited by 102 · see citing works

DJ-1 Null Dopaminergic Neuronal Cells Exhibit Defects in Mitochondrial Function and Structure: Involvement of Mitochondrial Complex I Assembly

Heo, J. Y., Park, J. H., Kim, S. J., Seo, K. S., Han, J., Lee, S. H., Kim, J., Park, J., Park, S. K., Lim, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032629 · Cited by 102 · see citing works

Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits

Beach, T. G., Sue, L. I., Walker, D. G., Lue, L. F., Connor, D. J., Caviness, J. N., Sabbagh, M. N., & Adler, C. H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0250-5 · Cited by 101 · see citing works

NADPH Oxidase 1 Mediates α-Synucleinopathy in Parkinson's Disease

Cristóvão, A. C., Guhathakurta, S., Bok, E., Je, G., Yoo, S. D., Choi, D., & Kim, Y. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2246-12.2012 · Cited by 98 · see citing works

Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine‐associated diseases

Gluck, M. R., & Zeevalk, G. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02747.x · Cited by 96 · see citing works

Loss of DJ-1 Does Not Affect Mitochondrial Respiration but Increases ROS Production and Mitochondrial Permeability Transition Pore Opening

Giaime, E., Yamaguchi, H., Gautier, C., Kitada, T., & Shen, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040501 · Cited by 94 · see citing works

Rotenone induces neuronal death by microglial phagocytosis of neurons

Emmrich, J., Hornik, T. C., Neher, J. J., & Brown, G. C. (2013) · FEBS Journal · doi:10.1111/febs.12401 · Cited by 93 · see citing works

Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease

Mytilineou, C., Werner, P., Molinari, S., Rocco, A. D., Cohen, G., & Yahr, M. D. (1994) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02260943 · Cited by 92 · see citing works

Rotenone Directly Induces BV2 Cell Activation via the p38 MAPK Pathway

Gao, F., Chen, D., Hu, Q., & Wang, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072046 · Cited by 91 · see citing works

Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4

Hauser, D. N., Dukes, A. A., Mortimer, A. D., & Hastings, T. G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.030 · Cited by 87 · see citing works

Convergence of Parkin, PINK1, and α-Synuclein on Stress-induced Mitochondrial Morphological Remodeling

Norris, K. L., Hao, R., Chen, L., Lai, C.-H., Kapur, M., Shaughnessy, P. J., Chou, D., Yan, J., Taylor, J. P., Engelender, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.634063 · Cited by 87 · see citing works

Novel LRRK2 GTP-binding inhibitors reduced degeneration in Parkinson's disease cell and mouse models

Li, T., Yang, D., Zhong, S., Thomas, J. M., Xue, F., Liu, J., Kong, L., Voulalas, P. J., Hassan, H. E., Park, J.-S., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu341 · Cited by 85 · see citing works

Overexpression of Parkin Ameliorates Dopaminergic Neurodegeneration Induced by 1- Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice

Bian, M., Liu, J., Hong, X., Yu, M., Huang, Y., Sheng, Z., Fei, J., & Huang, F. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039953 · Cited by 81 · see citing works

Mitochondrial membrane potential decrease caused by loss of PINK1 is not due to proton leak, but to respiratory chain defects

Amo, T., Sato, S., Saiki, S., Wolf, A. M., Toyomizu, M., Gautier, C., Shen, J., Ohta, S., & Hattori, N. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.027 · Cited by 79 · see citing works

MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview.

Jackson-Lewis, V. R., & Smeyne, R. J. (2005) · Neurotoxicity Research · doi:10.1007/bf03036449 · Cited by 77 · see citing works

Parkinson's disease and inflammatory changes

Barcia, C., Barreiro, A. F., Poza, M., & Herrero, M. T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033170 · Cited by 76 · see citing works

Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 and Cys-53

Girotto, S., Sturlese, M., Bellanda, M., Tessari, I., Cappellini, R., Bisaglia, M., Bubacco, L., & Mammi, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311589 · Cited by 73 · see citing works

Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson’s Disease

Belluzzi, E., Bisaglia, M., Lazzarini, E., Tabares, L. C., Beltramini, M., & Bubacco, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038026 · Cited by 71 · see citing works

Involvement and interplay of Parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders

Wilhelmus, M. M. M., Nijland, P. G., Drukarch, B., de Vries, H. E., & van Horssen, J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.040 · Cited by 62 · see citing works

Extended lifespan of Drosophila parkin mutants through sequestration of redox-active metals and enhancement of anti-oxidative pathways

Saini, N., Oelhafen, S., Hua, H., Georgiev, O., Schaffner, W., & Büeler, H. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.011 · Cited by 61 · see citing works

Vitamins K interact with N-terminus α-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and α-synuclein

da Silva, F. L., Cerqueira, E. C., de Freitas, M. S., Gonçalves, D. L., Costa, L. T., & Follmer, C. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.10.001 · Cited by 61 · see citing works

Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells

Garrido‐Gil, P., Rodríguez‐Pallares, J., Dominguez‐Meijide, A., Guerra, M. J., & Labandeira-García, J. L. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.013 · Cited by 51 · see citing works

Oxidative Stress Promotes Uptake, Accumulation, and Oligomerization of Extracellular α-Synuclein in Oligodendrocytes

Pukaß, K., & Richter‐Landsberg, C. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0154-x · Cited by 48 · see citing works

Nuclear translocation of alpha-synuclein increases susceptibility of MES23.5 cells to oxidative stress

Zhou, M., Xu, S., Mi, J., et al. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.024 · Cited by 47 · see citing works

Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis

Plum, S., Helling, S., Theiß, C., Leite, R. E. P., May, C., Jacob-Filho, W., Eisenacher, M., Kuhlmann, K., Meyer, H. E., Riederer, P. F., et al. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.07.015 · Cited by 46 · see citing works

Oral Treatment with the NADPH Oxidase Antagonist Apocynin Mitigates Clinical and Pathological Features of Parkinsonism in the MPTP marmoset Model

Philippens, I. H. C. H. M., Wubben, J. A. M., Finsen, B. R., & Hart, B. A. ‘. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9450-z · Cited by 44 · see citing works

Quantitative study of mitochondrial complex I in platelets of parkinsonian patients

Blandini, F., Nappi, G., & Timothy Greenamyre, J. (1998) · Movement Disorders · doi:10.1002/mds.870130106 · Cited by 44 · see citing works

The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging

Rodrı́guez, M., Moráles, I., Rodriguez‐Sabate, C., Sánchez, A., Castro, R., Armas, J. M. B., & Sabaté, M. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00080 · Cited by 43 · see citing works

Detailed analysis of mitochondrial respiratory chain defects caused by loss of PINK1

Amo, T., Saiki, S., Sawayama, T., Sato, S., & Hattori, N. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.045 · Cited by 34 · see citing works

Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: Implications in Parkinson's disease

Jana, S., Maiti, A. K., Bagh, M. B., Banerjee, K., Das, A., Roy, A., & Chakrabarti, S. (2007) · Brain Research · doi:10.1016/j.brainres.2006.09.100 · Cited by 33 · see citing works

Rotenone induces neurotoxicity through Rac1‐dependent activation of NADPH oxidase in SHSY‐5Y cells

Pal, R., Monroe, T. O., Palmieri, M., Sardiello, M., & Rodney, G. G. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.12.011 · Cited by 33 · see citing works

Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells

Li, J., Scheller, C., Koutsilieri, E., Carew‐Jones, F., Beart, P. M., Mercer, L. D., Halliday, G. M., Kettle, E., Rowe, D. B., Riederer, P. F., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03404.x · Cited by 32 · see citing works

Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons

Zhou, Z., Refai, F. S., Xie, S. P., Ng, S. H., Chan, C. H. S., Ho, P., Zhang, X. D., Lim, T. M., & Tan, E. K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.015 · Cited by 27 · see citing works

Etiology and Pathogenesis

Henner, N., & Davis, J. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-2155-9_69 · Cited by 20 · see citing works

Combined effect of dopamine and MPP+ on membrane permeability in mitochondria and cell viability in PC12 cells

Lee, C. S., Song, E. H., Park, S. Y., et al. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(02)00214-0 · Cited by 20 · see citing works

Glutathione-mediated reversibility of covalent modification of ubiquitin carboxyl-terminal hydrolase L1 by 1,2-naphthoquinone through Cys152, but not Lys4

Toyama, T., Shinkai, Y., Yazawa, A., et al. (2014) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.02.008 · Cited by 19 · see citing works

Parkinson's disease: animal models

Betarbet, R. S., & Greenamyre, J. T. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83011-9 · Cited by 18 · see citing works

OsDEG10 encoding a small RNA-binding protein is involved in abiotic stress signaling

Park, H., Kang, I., Han, J., et al. (2009) · Open Access System for Information Sharing (Pohang University of Science and Technology) · doi:10.1016/j.bbrc.2009 · Cited by 18 · see citing works

Increase of Secondary Processes of Microglial and Astroglial Cells After MPTP-Induced Degeneration in Substantia Nigra Pars Compacta of Non Human Primates

Barcia, C., Ros, C. M. B., Sauvage, M.-A. C.-D., Ros‐Bernal, F., Gómez, A., de Pablos, V., Bautista‐Hernández, V., Sánchez-Bahíllo, A., Fernández‐Villalba, E., & Herrero, M. T. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_20 · Cited by 11 · see citing works

Complex I Deficiency

Simon, D. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374105-9.00229-x · Cited by 2 · see citing works

The role of oxidative stress in neurodegenerative diseases

Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · see citing works

Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease

Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works

Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives

Hajam, Y. A., Rani, R., Ganie, S. Y., Sheikh, T. A., Javaid, D., Qadri, S. S., Pramodh, S., Alsulimani, A., Alkhanani, M. F., Harakeh, S., et al. (2022) · Cells · doi:10.3390/cells11030552 · Cited by 915 · see citing works

Role of ROS and Nutritional Antioxidants in Human Diseases

Liu, Z., Ren, Z., Zhang, J., Chuang, C.-C., Kandaswamy, E., Zhou, T., & Zuo, L. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00477 · Cited by 860 · see citing works

Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications

Pajares, M., I. Rojo, A., Manda, G., Boscá, L., & Cuadrado, A. (2020) · Cells · doi:10.3390/cells9071687 · Cited by 779 · see citing works

Ageing, age-related diseases and oxidative stress: What to do next?

Luo, J., Mills, K., le Cessie, S., Noordam, R., & van Heemst, D. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100982 · Cited by 581 · see citing works

NADPH oxidase in brain injury and neurodegenerative disorders

Ma, M. W., Wang, J., Zhang, Q., Wang, R., Dhandapani, K. M., Vadlamudi, R. K., & Brann, D. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0150-7 · Cited by 432 · see citing works

Brain lipidomics: From functional landscape to clinical significance

Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324 · see citing works

Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity: Supplementary Issue: Brain Plasticity and Repair

Beckhauser, T. F., Francis-Oliveira, J., & De Pasquale, R. (2016) · Journal of Experimental Neuroscience · doi:10.4137/jen.s39887 · Cited by 301 · see citing works

The Glutathione System in Parkinson’s Disease and Its Progression

Bjørklund, G., Peana, M., Maes, M., Dadar, M., & Severin, B. (2021) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.10.004 · Cited by 186 · see citing works

Lactobacillus Plantarum PS128 Alleviates Neurodegenerative Progression in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Models of Parkinson’s Disease

Liao, J.-F., Cheng, Y.-F., You, S.-T., Kuo, W.-C., Huang, C.-W., Chiou, J.-J., Hsu, C.-C., Hsieh-Li, H.-M., Wang, S., & Tsai, Y.-C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.07.036 · Cited by 159 · see citing works

A novel role of NLRP3-generated IL-1β in the acute-chronic transition of peripheral lipopolysaccharide-elicited neuroinflammation: implications for sepsis-associated neurodegeneration

Zhao, Z., Wang, Y., Zhou, R., Li, Y., Gao, Y., Tu, D., Wilson, B., Song, S., Feng, J., Hong, J.-S., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1728-5 · Cited by 109 · see citing works

Does PGC1α/FNDC5/BDNF Elicit the Beneficial Effects of Exercise on Neurodegenerative Disorders?

Jodeiri Farshbaf, M., Ghaedi, K., Megraw, T. L., Curtiss, J., Shirani Faradonbeh, M., Vaziri, P., & Nasr-Esfahani, M. H. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8370-x · Cited by 101 · see citing works

A review on therapeutic potentials of <i>Trigonella foenum graecum</i> (fenugreek) and its chemical constituents in neurological disorders: Complementary roles to its hypolipidemic, hypoglycemic, and antioxidant potential

Zameer, S., Najmi, A. K., Vohora, D., & Akhtar, M. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1327200 · Cited by 74 · see citing works

Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson’s disease

Zhang, Y., He, X., Wu, X., Lei, M., Wei, Z., Zhang, X., Wen, L., Xu, P., Li, S., & Qu, S. (2017) · Cell Death &amp; Disease · doi:10.1038/cddis.2016.491 · Cited by 66 · see citing works

Phenolic Melatonin-Related Compounds: Their Role as Chemical Protectors against Oxidative Stress

Galano, A., Castañeda-Arriaga, R., Pérez-González, A., Tan, D.-X., & Reiter, R. (2016) · Molecules · doi:10.3390/molecules21111442 · Cited by 60 · see citing works

Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm

Josephy-Hernandez, S., Jmaeff, S., Pirvulescu, I., Aboulkassim, T., & Saragovi, H. U. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.004 · Cited by 54 · see citing works

Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s Disease

Leggio, L., Paternò, G., Vivarelli, S., Falzone, G. G., Giachino, C., Marchetti, B., & Iraci, N. (2021) · Aging and disease · doi:10.14336/ad.2021.0527 · Cited by 55 · see citing works

Prognostic biomarkers of Parkinson’s disease in the Spanish EPIC cohort: a multiplatform metabolomics approach

Gonzalez-Riano, C., Saiz, J., Barbas, C., Bergareche, A., Huerta, J. M., Ardanaz, E., Konjevod, M., Mondragon, E., Erro, M. E., Chirlaque, M. D., et al. (2021) · npj Parkinson's Disease · doi:10.1038/s41531-021-00216-4 · Cited by 49 · see citing works

Inflammation-induced motivational changes: Perspective gained by evaluating positive and negative valence systems

Vichaya, E. G., & Dantzer, R. (2018) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2018.01.008 · Cited by 47 · see citing works

Linking chronic kidney disease and Parkinson’s disease: a literature review

Meléndez-Flores, J. D., & Estrada-Bellmann, I. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00623-1 · Cited by 44 · see citing works

Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson’s model

Pradhan, P., Majhi, O., Biswas, A., Joshi, V. K., & Sinha, D. (2020) · Cell Death &amp; Disease · doi:10.1038/s41419-020-02942-8 · Cited by 44 · see citing works

Alternative platelet activation pathways and their role in neurodegenerative diseases

Ferrer-Raventós, P., & Beyer, K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105512 · Cited by 39 · see citing works

Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy

Mendes, M. O., Rosa, A. I., Carvalho, A. N., Nunes, M. J., Dionísio, P., Rodrigues, E., Costa, D., Duarte-Silva, S., Maciel, P., Rodrigues, C. M. P., et al. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.01.003 · Cited by 31 · see citing works

The insect molting hormone 20-hydroxyecdysone protects dopaminergic neurons against MPTP-induced neurotoxicity in a mouse model of Parkinson’s disease

Lim, H.-S., Moon, B. C., Lee, J., Choi, G., & Park, G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.010 · Cited by 30 · see citing works

Bacopa monnieri supplements offset paraquat-induced behavioral phenotype and brain oxidative pathways in mice

Krishna, G., Hosamani, R., & Muralidhara (2019) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524919666190115125900 · Cited by 16 · see citing works

Behavior alteration and damage of dopaminergic neurons of substantia nigra caused by rotenone in rats

Ren, Y. (2011) · Jiepou kexue jinzhan

Influence of activated microglia on the dopaminergic neurons of substantia nigra in rats model of Parkinson's disease by rotenone

Ren, Y. (2011) · Jiepou kexue jinzhan

The effect of rotenone on the dopaminergic cells of the substantia nigra of the midbrain in the adult male albino rats

Mahmod, M. A.-R., Galhom, R. A., El‐Din, W. A. N., et al. (2017) · Sohag Medical Journal · doi:10.21608/smj.2017.40762

Toxic Effects of Rotenone on Substantia Nigra of Rats

Dong, Z. (2007) · Journal of environmental health

Histopathologic Changes in the Substantia Nigra Resulted by Paraquat Intoxication in Rat

Sabbagh, A., Tavasoly, A., Amoli, J. S., et al. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.4.41 · Cited by 1 · see citing works